Cardiac Surgery

REDUCE: GORE® HELEX® Septal Occluder / GORE® Septal Occluder for Patent Foramen Ovale (PFO) Closure in Stroke Patients - The Gore REDUCE Clinical Study (HLX 06-03).

PURPOSE: The primary objective is to determine that patent foramen ovale (PFO) closure with the GORE® HELEX® Septal Occluder / GORE® Septal Occluder plus antiplatelet medical management is safe and effective and reduces the risk of recurrent stroke or imaging-confirmed transient ischemic attack (TIA) when compared to antiplatelet medical management alone in patients with a PFO and history of cryptogenic stroke or imaging-confirmed TIA.

To learn more, contact:
Black Hills
Cardiovascular Research

4150 5th Street
Rapid City, SD

(605) 755-4326

Principal Investigator
Joseph L. Tuma, MD, FACC
Cardiologist